Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Institute Installs Sequenom’s MassArray And Genomica Software

Premium

G

AITHERSBURG, Md.--Sequenom has installed its MassArray system at the US National Cancer Institute’s Advanced Technology Center here for use in analysis of single-nucleotide polymorphisms that occur in genes involved with cancer and other diseases. The system combines Sequenom’s proprietary enzymology and bioinformatics in a miniaturized chip-based format with mass spectrometry technology. The deal marks the third installation by the German company of its MassArray system in the US, and the fifth worldwide.

The cancer institute also recently licensed pharmaco-genomics tools from Genomica. Genomica’s CEO Theresa Ayers said her company’s Discovery Manager tool will enable the institute to integrate the data in its bioinformatics pipeline, from pedigree information to the linkage analysis and sequence analysis stages of disease studies.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.